This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Repligen Corp (RGEN)

NASDAQ: Health Care

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 83.54M 63.55M 68.17M 62.27M
Cost of Sales 30.66M 24.00M 22.05M 23.66M
Gross Operating Profit 52.88M 39.55M 46.12M 38.60M
Selling, General, and Administrative Expenses 24.70M 17.15M 12.70M 13.23M
Research & Development 5.74M 5.61M 7.34M 10.49M
Operating Income before D & A (EBITDA) 22.44M 16.78M 26.08M 14.89M
Depreciation & Amortization 4.59M 4.02M 3.11M 3.51M
Interest Income 136.00K 309.47K 301.08K 218.60K
Other Income - Net -445.00K 188.00K -201.84K 340.65K
Special Income / Charges -4.08M -2.07M 0.00 -610.88K
Total Income Before Interest Expenses (EBIT) 13.46M 11.19M 23.06M 11.33M
Interest Expense 32.00K 49.96K 49.85K 56.71K
Pre-Tax Income 13.42M 11.14M 23.01M 11.27M
Income Taxes 4.08M 2.97M 6.92M -2.88M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 9.35M 8.17M 16.09M 14.16M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 9.35M 8.17M 16.09M 14.16M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 9.35M 8.17M 16.09M 14.16M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
13.43M 10.24M 16.09M 14.77M
Preferred Dividends
Net Income Available To Common 9.35M 8.17M 16.09M 14.16M
Basic EPS from Continuing Ops. 0.28 0.25 0.51 0.46
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.28 0.25 0.51 0.46
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.28 0.25 0.51 0.46
Basic Normalized Net Income/Share 0.41 0.32 0.51 0.48
EPS fr Continuing Ops. 0.28 0.25 0.50 0.45
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.28 0.25 0.50 0.45
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.28 0.25 0.50 0.45
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.40 0.31 0.50 0.47
Dividends Paid per Share 0.00 0.00 0.00 0.00
RGEN News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for RGEN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 2
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET RGEN ANALYST REPORT

RGEN Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs